NO20002167L - Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler - Google Patents

Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler

Info

Publication number
NO20002167L
NO20002167L NO20002167A NO20002167A NO20002167L NO 20002167 L NO20002167 L NO 20002167L NO 20002167 A NO20002167 A NO 20002167A NO 20002167 A NO20002167 A NO 20002167A NO 20002167 L NO20002167 L NO 20002167L
Authority
NO
Norway
Prior art keywords
oral contraceptives
containing oral
estrogen plus
plus progestin
progestin
Prior art date
Application number
NO20002167A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002167D0 (no
Inventor
Michael Jay Gast
Christopher Paul Miller
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO20002167D0 publication Critical patent/NO20002167D0/no
Publication of NO20002167L publication Critical patent/NO20002167L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20002167A 1997-11-06 2000-04-27 Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler NO20002167L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96508397A 1997-11-06 1997-11-06
PCT/US1998/023427 WO1999024027A2 (en) 1997-11-06 1998-11-04 Anti-estrogen plus progestin containing oral contraceptives

Publications (2)

Publication Number Publication Date
NO20002167D0 NO20002167D0 (no) 2000-04-27
NO20002167L true NO20002167L (no) 2000-06-28

Family

ID=25509417

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002167A NO20002167L (no) 1997-11-06 2000-04-27 Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler

Country Status (28)

Country Link
EP (1) EP1051179B1 (pt)
JP (1) JP2001522798A (pt)
CN (1) CN1278732A (pt)
AR (1) AR016667A1 (pt)
AT (1) ATE304359T1 (pt)
AU (2) AU760540B2 (pt)
BG (1) BG104451A (pt)
BR (1) BR9813982A (pt)
CA (1) CA2307210A1 (pt)
CZ (1) CZ294155B6 (pt)
DE (1) DE69831605T2 (pt)
DK (1) DK1051179T3 (pt)
EA (1) EA200000492A1 (pt)
EE (1) EE04092B1 (pt)
ES (1) ES2246541T3 (pt)
GE (1) GEP20043290B (pt)
HR (1) HRP20000269A2 (pt)
HU (1) HUP0100293A3 (pt)
ID (1) ID24568A (pt)
IL (1) IL135621A0 (pt)
NO (1) NO20002167L (pt)
NZ (1) NZ503890A (pt)
PL (1) PL340623A1 (pt)
SK (1) SK6482000A3 (pt)
TR (1) TR200001268T2 (pt)
UA (1) UA68365C2 (pt)
WO (1) WO1999024027A2 (pt)
ZA (1) ZA9810136B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
UA66861C2 (uk) * 1998-05-15 2004-06-15 Уайт 2-феніл-1-[4-(2-аміноетокси)бензил]індол в комбінації з естрогенами, способи лікування та продукт для лікування
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
WO2001019839A1 (en) * 1999-09-13 2001-03-22 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols
US6376486B1 (en) * 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
WO2003011282A1 (en) 2001-07-31 2003-02-13 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
EP1809602B1 (en) 2004-10-27 2008-10-29 Janssen Pharmaceutica N.V. Indole derivatives useful as progesterone receptor modulators
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
UY29527A1 (es) * 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
EP2580210B1 (en) 2010-06-10 2017-03-01 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
US9187460B2 (en) 2011-12-14 2015-11-17 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
AU2016331065B2 (en) 2015-10-01 2021-04-29 Olema Pharmaceuticals, Inc. Tetrahydro-1H-pyrido(3,4-b)indole anti-estrogenic drugs
EP3386968A4 (en) 2015-12-09 2019-09-25 The Board of Trustees of the University of Illinois BENZOTHIOPHEN-BASED SELECTIVE ESTROGEN RECEPTOR-DOWN-REGULATING PREPARATIONS
EP3455218A4 (en) 2016-05-10 2019-12-18 C4 Therapeutics, Inc. C3 CARBON-BASED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION
EP3454856A4 (en) 2016-05-10 2019-12-25 C4 Therapeutics, Inc. HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN REDUCTION
WO2017197036A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Spirocyclic degronimers for target protein degradation
CN109789143A (zh) 2016-07-01 2019-05-21 G1治疗公司 基于嘧啶的抗增殖剂
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
BR112019013814A2 (pt) 2017-01-06 2020-01-21 G1 Therapeutics Inc método para tratamento de câncer ou de um tumor em um indivíduo, composição farmacêutica, combinação, e, kit.
AU2018217809A1 (en) 2017-02-10 2019-08-22 G1 Therapeutics, Inc. Benzothiophene estrogen receptor modulators
WO2019006393A1 (en) 2017-06-29 2019-01-03 G1 Therapeutics, Inc. MORPHIC FORMS OF GIT38 AND METHODS OF MAKING SAME
CN113453679A (zh) 2018-12-20 2021-09-28 C4医药公司 靶向蛋白降解
WO2024030968A1 (en) 2022-08-03 2024-02-08 Brystol-Myers Squibb Company Compounds for modulating ret protein
WO2024097989A1 (en) 2022-11-04 2024-05-10 Bristol-Myers Squibb Company Ret-ldd protein degraders
WO2024097980A1 (en) 2022-11-04 2024-05-10 Bristol-Myers Squibb Company Ret-ldd protein inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA716118B (en) * 1970-10-05 1972-05-31 Richardson Merrell Inc Contraception
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
DK0802183T3 (da) * 1996-04-19 2002-02-04 American Home Prod Østrogenforbindelser
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
SK6482000A3 (en) 2000-11-07
ATE304359T1 (de) 2005-09-15
EE200000211A (et) 2001-04-16
AU760540B2 (en) 2003-05-15
WO1999024027A3 (en) 1999-07-15
UA68365C2 (en) 2004-08-16
CN1278732A (zh) 2001-01-03
BR9813982A (pt) 2000-09-26
ZA9810136B (en) 2000-05-05
GEP20043290B (en) 2004-07-26
EP1051179B1 (en) 2005-09-14
BG104451A (en) 2000-12-29
EE04092B1 (et) 2003-08-15
CZ20001661A3 (cs) 2000-12-13
WO1999024027A2 (en) 1999-05-20
ID24568A (id) 2000-07-27
HUP0100293A3 (en) 2002-12-28
DK1051179T3 (da) 2005-10-31
NO20002167D0 (no) 2000-04-27
TR200001268T2 (tr) 2001-01-22
EA200000492A1 (ru) 2000-10-30
JP2001522798A (ja) 2001-11-20
CZ294155B6 (cs) 2004-10-13
HRP20000269A2 (en) 2000-12-31
AR016667A1 (es) 2001-07-25
DE69831605T2 (de) 2006-06-14
AU2003204896B2 (en) 2006-06-15
EP1051179A2 (en) 2000-11-15
PL340623A1 (en) 2001-02-12
CA2307210A1 (en) 1999-05-20
IL135621A0 (en) 2001-05-20
DE69831605D1 (de) 2005-10-20
NZ503890A (en) 2002-08-28
ES2246541T3 (es) 2006-02-16
AU1303199A (en) 1999-05-31
HUP0100293A2 (hu) 2001-10-28

Similar Documents

Publication Publication Date Title
DK1051179T3 (da) Anti-estrogen- plus progestin-holdige orale kontraceptiva
ID20233A (id) Komposisi oral
NO993096D0 (no) Orale cyklosporinformuleringer
DE59802830D1 (de) Orthesengelenk
DE69827710D1 (de) Kippbecken-WC
DE69805807T2 (de) Mikrobiozide n-sulfonylglycin-alkynyloxyphenethylamid-derivate
ITMI991826A0 (it) Nuova formulazione orale
DE69821845D1 (de) Ostomievorrichtung
DK1334725T3 (da) Östroprogestativt antikonceptionsmiddel
ID20466A (id) Komposisi oral
DE69907677D1 (de) Brennstoff-luft-mischgerät
ID19885A (id) Tisu lembab
DK0853933T3 (da) Ostomikobling
DE69832127D1 (de) Wässrige Siliconzusammensetzung
ID20328A (id) Toilet
DE29715802U1 (de) Schluckbrunnen
DE29714900U1 (de) Säschar-Kombination
DE29700629U1 (de) Sanitäranordnung
DE29700260U1 (de) Kondom
DE29705376U1 (de) Mundschutzkondom
DE69804179D1 (de) Photoempfindliche Zusammensetzung
DE29720643U1 (de) Hysteroskop
DE29810866U1 (de) Kondom-Aufsetzgerät
DE69823079D1 (de) Bissanzeiger
DE29722623U1 (de) Condomabroller

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application